{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:29:53Z","timestamp":1778254193303,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1208\/s12249-018-0952-0","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T17:08:10Z","timestamp":1519146490000},"page":"1468-1476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Improving Properties of Albendazole Desmotropes by Supramolecular Systems with Maltodextrin and Glutamic Acid"],"prefix":"10.1208","volume":"19","author":[{"given":"Agustina","family":"Bongioanni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Sousa","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara Santiago","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela R.","family":"Longhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Garnero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"key":"952_CR1","unstructured":"Bauer JF. Polymorphism: a critical consideration in pharmaceutical development, manufacturing and stability. J Technol. 2008;15\u201323."},{"issue":"2","key":"952_CR2","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/jps.22788","volume":"101","author":"HG Brittain","year":"2012","unstructured":"Brittain HG. Polymorphism and solvatomorphism 2010. J Pharm Sci. 2012;101(2):464\u201384. \n                    https:\/\/doi.org\/10.1002\/jps.22788\n                    \n                  .","journal-title":"J Pharm Sci"},{"key":"952_CR3","first-page":"1239","volume-title":"Farmacolog\u00eda Humana","author":"J Fl\u00f3rez","year":"1998","unstructured":"Fl\u00f3rez J. F\u00e1rmacos antiparasitarios. II. Helmintos y artr\u00f3podos. In: Farmacolog\u00eda Humana. Barcelona: Masson S.A.; 1998. p. 1239\u201347."},{"issue":"3","key":"952_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ejpb.2010.03.017","volume":"75","author":"MG Barrera","year":"2010","unstructured":"Barrera MG, Leonardi D, Bolmaro RE, Echenique CG, Olivieri AC, Salomon CJ, et al. In vivo evaluation of albendazole microspheres for the treatment of Toxocara canis larva migrans. Eur J Pharm Biopharm. 2010;75(3):451\u20134. \n                    https:\/\/doi.org\/10.1016\/j.ejpb.2010.03.017\n                    \n                  .","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"952_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.parint.2013.08.009","volume":"62","author":"A Garc\u00eda","year":"2013","unstructured":"Garc\u00eda A, Barrera MG, Piccirilli G, Vasconi MD, Di Masso RJ, Leonardi D, et al. Novel albendazole formulations given during the intestinal phase of Trichinella spiralis infection reduce effectively parasitic muscle burden in mice. Parasitol Int. 2013;62(6):568\u201370. \n                    https:\/\/doi.org\/10.1016\/j.parint.2013.08.009\n                    \n                  .","journal-title":"Parasitol Int"},{"key":"952_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.actatropica.2017.03.018","volume":"171","author":"N Solomon","year":"2017","unstructured":"Solomon N, Kachani M, Zeyhle E, Macpherson CNL. The natural history of cystic echinococcosis in untreated and albendazole treated patients. Acta Trop. 2017;171:52\u20137. \n                    https:\/\/doi.org\/10.1016\/j.actatropica.2017.03.018\n                    \n                  .","journal-title":"Acta Trop"},{"issue":"3","key":"952_CR7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1021\/mp500539g","volume":"12","author":"AK Chattah","year":"2015","unstructured":"Chattah AK, Zhang R, Mroue KH, Pfund LY, Longhi MR, Ramamoorthy A, et al. Investigating albendazole desmotropes by solid-state NMR spectroscopy. Mol Pharm. 2015;12(3):731\u201341. \n                    https:\/\/doi.org\/10.1021\/mp500539g\n                    \n                  .","journal-title":"Mol Pharm"},{"issue":"9","key":"952_CR8","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1002\/jps.22072","volume":"99","author":"MB Pranzo","year":"2010","unstructured":"Pranzo MB, Cruickshank D, Coruzzi M, Caira MR, Bettini R. Enantiotropically related albendazole polymorphs. J Pharm Sci. 2010;99(9):3731\u201342. \n                    https:\/\/doi.org\/10.1002\/jps.22072\n                    \n                  .","journal-title":"J Pharm Sci"},{"issue":"1-2","key":"952_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijpharm.2016.01.006","volume":"499","author":"L Martinez","year":"2016","unstructured":"Martinez L, Lamprou DA, McBurney RT, Halbert GW. A novel hot-melt extrusion formulation of albendazole for increasing dissolution properties. Int J Pharm. 2016;499(1-2):175\u201385. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2016.01.006\n                    \n                  .","journal-title":"Int J Pharm"},{"issue":"4","key":"952_CR10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1208\/s12249-016-0659-z","volume":"18","author":"J Priotti","year":"2017","unstructured":"Priotti J, Codina AV, Leonardi D, Vasconi MD, Hinrichsen LI, Lamas MC. Albendazole microcrystal formulations based on chitosan and cellulose derivatives: physicochemical characterization and in vitro parasiticidal activity in Trichinella spiralis adult worms. AAPS PharmSciTech. 2017;18(4):947\u201356. \n                    https:\/\/doi.org\/10.1208\/s12249-016-0659-z\n                    \n                  .","journal-title":"AAPS PharmSciTech"},{"key":"952_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.carres.2014.06.008","volume":"398","author":"B Pradines","year":"2014","unstructured":"Pradines B, Gallard JF, Iorga BI, Gueutin C, Loiseau PM, Ponchel G, et al. Investigation of the complexation of albendazole with cyclodextrins for the design of new antiparasitic formulations. Carbohydr Res. 2014;398:50\u20135. \n                    https:\/\/doi.org\/10.1016\/j.carres.2014.06.008\n                    \n                  .","journal-title":"Carbohydr Res"},{"key":"952_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.carbpol.2017.01.098","volume":"164","author":"AK Chattah","year":"2017","unstructured":"Chattah AK, Pfund LY, Zoppi A, Longhi MR, Garnero C. Toward novel antiparasitic formulations: complexes of albendazole desmotropes and \u03b2-cyclodextrin. Carbohydr Polym. 2017;164:379\u201385. \n                    https:\/\/doi.org\/10.1016\/j.carbpol.2017.01.098\n                    \n                  .","journal-title":"Carbohydr Polym"},{"issue":"5","key":"952_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.apt.2011.06.005","volume":"23","author":"A Gurrapu","year":"2012","unstructured":"Gurrapu A, Jukanti R, Bobbala SR, Kanuganti S, Jeevana JB. Improved oral delivery of valsartan from maltodextrin based proniosome powders. Adv Powder Technol. 2012;23(5):583\u201390. \n                    https:\/\/doi.org\/10.1016\/j.apt.2011.06.005\n                    \n                  .","journal-title":"Adv Powder Technol"},{"issue":"5","key":"952_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.apsb.2014.08.001","volume":"4","author":"R Ku","year":"2014","unstructured":"Ku R, Sahoo N, Arijit Guha B, Sahoo N, Kuotsu K. Development and in vitro\/in vivo evaluation of controlled release provesicles of a nateglinide maltodextrin complex. Acta Pharma Sin B. 2014;4(5):408\u201316.","journal-title":"Acta Pharma Sin B"},{"issue":"3","key":"952_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1208\/s12249-016-0572-5","volume":"18","author":"J Zhang","year":"2017","unstructured":"Zhang J, Zhang X, Wang X, Huang Y, Yang B, Pan X, et al. The influence of maltodextrin on the physicochemical properties and stabilization of beta-carotene emulsions. AAPS PharmSciTech. 2017;18(3):821\u20138. \n                    https:\/\/doi.org\/10.1208\/s12249-016-0572-5\n                    \n                  .","journal-title":"AAPS PharmSciTech"},{"key":"952_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.carbpol.2014.11.017","volume":"121","author":"V Aiassa","year":"2014","unstructured":"Aiassa V, Zoppi A, Albesa I, Longhi MR. Inclusion complexes of chloramphenicol with \u03b2-cyclodextrin and aminoacids as a way to increase drug solubility and modulate Ros production. Carbohydr Polym. 2014;121:320\u20137. \n                    https:\/\/doi.org\/10.1016\/j.carbpol.2014.11.017\n                    \n                  .","journal-title":"Carbohydr Polym"},{"issue":"3","key":"952_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ejmech.2007.03.037","volume":"43","author":"GE Granero","year":"2008","unstructured":"Granero GE, Maitre MM, Garnero C, Longhi MR. Synthesis, characterization and in vitro release studies of a new acetazolamide\u2013HP-\u03b2-CD\u2013TEA inclusion complex. Eur J Med Chem. 2008;43(3):464\u201370. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2007.03.037\n                    \n                  .","journal-title":"Eur J Med Chem"},{"key":"952_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.carbpol.2014.11.017","volume":"121","author":"V Aiassa","year":"2015","unstructured":"Aiassa V, Zoppi A, Albesa I, Longhi MR. Inclusion complexes of chloramphenicol with \u03b2-cyclodextrin and aminoacids as a way to increase drug solubility and modulate ROS production. Carbohyd Pol. 2015;121:320\u20137. \n                    https:\/\/doi.org\/10.1016\/j.carbpol.2014.11.017\n                    \n                  .","journal-title":"Carbohyd Pol"},{"issue":"2","key":"952_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0378-5173(03)00265-5","volume":"260","author":"P Mura","year":"2003","unstructured":"Mura P, Maestrelli F, Cirri M. Ternary systems of naproxen with hydroxypropyl-\u03b2-cyclodextrin and aminoacids. Int J Pharm. 2003;260(2):293\u2013302. \n                    https:\/\/doi.org\/10.1016\/S0378-5173(03)00265-5\n                    \n                  .","journal-title":"Int J Pharm"},{"key":"952_CR20","first-page":"117","volume-title":"Analytical chemistry and instrumentation","author":"T Higuchi","year":"1965","unstructured":"Higuchi T, Connors KA. Phase-solubility techniques in advances. In: Analytical chemistry and instrumentation, vol. 4. New York: Interscience; 1965. p. 117\u2013212."},{"key":"952_CR21","first-page":"64","volume":"20","author":"WJ Moore","year":"1996","unstructured":"Moore WJ, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol. 1996;20:64\u201374.","journal-title":"Pharm Technol"},{"issue":"1-2","key":"952_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0378-5173(01)00651-2","volume":"220","author":"P Costa","year":"2001","unstructured":"Costa P. An alternative method to the evaluation of similarity factor in dissolution testing. Int J Pharm. 2001;220(1-2):77\u201383. \n                    https:\/\/doi.org\/10.1016\/S0378-5173(01)00651-2\n                    \n                  .","journal-title":"Int J Pharm"},{"issue":"01","key":"952_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4236\/pp.2013.41003","volume":"4","author":"C Garnero","year":"2013","unstructured":"Garnero C, Aloisio M, Longhi M. Ibuprofen-maltodextrin interaction: study of enantiomeric recognition and complex characterization. Pharmacol Pharm. 2013;4(01):18\u201330. \n                    https:\/\/doi.org\/10.4236\/pp.2013.41003\n                    \n                  .","journal-title":"Pharmacol Pharm"},{"issue":"2","key":"952_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","volume":"58","author":"M Lindenberg","year":"2004","unstructured":"Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 2004;58(2):265\u201378. \n                    https:\/\/doi.org\/10.1016\/j.ejpb.2004.03.001\n                    \n                  .","journal-title":"Eur J Pharm Biopharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-018-0952-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-0952-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-0952-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:06:41Z","timestamp":1550621201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-018-0952-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-0952-0","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"18 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}